Calcium-activated potassium channels and NO regulate human peripheral conduit artery mechanics

被引:21
作者
Bellien, J
Joannides, R
Iacob, M
Arnaud, P
Thuillez, C
机构
[1] Rouen Univ Hosp, Dept Pharmacol, Rouen, France
[2] Rouen Univ Hosp, Dept Pharm, Rouen, France
关键词
arteries; elasticity; compliance; nitric oxide; potassium channels; endothelium-derived factors;
D O I
10.1161/01.HYP.0000165685.83620.31
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The role of NO in the regulation of the mechanical properties of conduit arteries is controversial in humans, and the involvement of an endothelium-derived hyperpolarizing factor ( EDHF), acting through calcium-activated potassium (K-Ca) channels, has never been investigated at this level in vivo. We assessed in healthy volunteers, after oral administration of aspirin ( 500 mg), the effect of local infusion of N-G-monomethyl-L-arginine (L-NMMA; 8 mu mol/min for 8 minutes), an NO synthase inhibitor, tetraethylammonium chloride ( TEA; 9 mu mol/min for 8 minutes), a K-Ca channels inhibitor, and the combination of both on radial artery internal diameter, wall thickness ( echo tracking), blood flow ( Doppler), and pressure. The incremental elastic modulus and compliance were fitted as functions of midwall stress. L-NMMA decreased modulus and increased compliance at high levels of midwall stress ( all P < 0.05) without affecting radial diameter. TEA reduced radial diameter from 2.68 +/- 0.07 to 2.50 +/- 0.08 10(-3) m, increased the modulus, and decreased the compliance at all levels of stress ( all P < 0.05). Combination of both inhibitors synergistically enhanced the increase in modulus, the decrease in diameter ( from 2.71 +/- 0.10 to 2.42 +/- 0.09 10(-3) m), and compliance compared with TEA alone ( all P < 0.05). These results confirm that inhibition of NO synthesis is associated with a paradoxical isometric smooth muscle relaxation of the radial artery. They demonstrate the involvement of K-Ca channels in the regulation of the mechanical properties of peripheral conduit arteries, supporting a role for EDHF at this level in vivo. Moreover, the synergistic effect of L-NMMA and TEA shows that K-Ca channels compensate for the loss of NO synthesis to maintain peripheral conduit artery diameter and mechanics.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 46 条
  • [31] MEISTER JJ, 1992, J HYPERTENS, V10, pS23
  • [32] DEVELOPMENT AND MECHANISM OF A SPECIFIC SUPERSENSITIVITY TO NITROVASODILATORS AFTER INHIBITION OF VASCULAR NITRIC-OXIDE SYNTHESIS INVIVO
    MONCADA, S
    REES, DD
    SCHULZ, R
    PALMER, RMJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) : 2166 - 2170
  • [33] Mullen MJ, 2001, CIRC RES, V88, P145
  • [34] ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION CAUSED BY BRADYKININ IN HUMAN CORONARY-ARTERIES
    NAKASHIMA, M
    MOMBOULI, JV
    TAYLOR, AA
    VANHOUTTE, PM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) : 2867 - 2871
  • [35] Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor - A modulator of arterial compliance
    Popp, R
    Fleming, I
    Busse, R
    [J]. CIRCULATION RESEARCH, 1998, 82 (06) : 696 - 703
  • [36] Flow-mediated vasodilation of human epicardial coronary arteries: Effect of inhibition of nitric oxide synthesis
    Shiode, N
    Morishima, N
    Nakayama, K
    Yamagata, T
    Matsuura, H
    Kajiyama, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (02) : 304 - 310
  • [37] Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans
    Stewart, AD
    Millasseau, SC
    Kearney, MT
    Ritter, JM
    Chowienczyk, PJ
    [J]. HYPERTENSION, 2003, 42 (05) : 915 - 918
  • [38] Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids
    Sun, JX
    Sui, XX
    Bradbury, JA
    Zeldin, DC
    Conte, MS
    Liao, JK
    [J]. CIRCULATION RESEARCH, 2002, 90 (09) : 1020 - 1027
  • [39] Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients
    Taddei, S
    Ghiadoni, L
    Virdis, A
    Buralli, S
    Salvetti, A
    [J]. CIRCULATION, 1999, 100 (13) : 1400 - 1405
  • [40] TARDY Y, 1992, J HYPERTENS, V10, pS105